Skip to content
Psychiatrist.com Logo
  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Advanced Search

Menu

  • JCP
  • PCC
  • News
  • CME
  • About
  • Authors & Reviewers
  • Sign In
  • Subscribe
Sign in Subscribe

Clinical Topics

View All
  • Addiction
  • ADHD
  • Alzheimer’s Disease
  • Anxiety
  • Bipolar Disorder
  • Depression
  • Movement Disorders
  • Neurology
  • OCD
  • Psychopharmacology
  • PTSD and Trauma
  • Schizophrenia/Schizoaffective Disorders
  • Sleep
  • Tardive Dyskinesia
  • View All

Collections

View All
  • Academic Highlights
  • Auvelity: Information from Industry
  • Banner Alzheimer’s Institute
  • Clinical & Practical Psychopharmacology
  • Early Career Psychiatrists
  • Focus on Childhood and Adolescent Mental Health
  • Focus on Geriatric Psychiatry
  • Focus on Psychotherapy
  • Focus on Suicide
  • Focus on Psychosis
  • Focus on Women’s Mental Health
  • Rounds in the General Hospital
  • UZEDY: Information from Industry
  • View All
Back to top Open menu arrow
Download PDF Reprints
No sections available

The Journal of
Clinical Psychiatry

Free access
Schizophrenia/Schizoaffective Disorders

Article July 16, 2007

Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap

Peter J. Weiden; Daniel Carpenter; Ruth Ross; John P. Docherty; Sheldon H. Preskorn; Peter A. Fahnestock

J Clin Psychiatry 2007;68(suppl 7):1-44

Article Abstract
Translating the Psychopharmacology of Antipsychotics to Individualized Treatment for Severe Mental Illness: A Roadmap

 

About the Authors

  • Peter J. Weiden
    View full profile
  • Daniel Carpenter
    View full profile
  • Ruth Ross
    View full profile
  • John P. Docherty
    View full profile
  • Sheldon H. Preskorn
    View full profile
  • Peter A. Fahnestock
    View full profile
Download Free PDF

This PDF is free for all visitors!

Announcement: The Journal of Clinical Psychiatry launches a new podcast. Click to learn more.

Related JCP Articles

Life After Clozapine: Managing Treatment-Resistant Schizophrenia When Clozapine Is No Longer an Option Efficacy of Olanzapine/Samidorphan on Negative Symptoms Clinical pearls of early use of Xanomeline–Trospium in the in-patient setting with Michael Halassa MD, PhD

Related PCC Articles

Cotard Syndrome in Schizophrenia Tetrabenazine-Induced Suicidality Psychosis Screening in Genetic Disorders
Cover features March 2026 issue highlighting articles on psychiatric drugs, peer interventions for perinatal depression, and metformin.

Vol 87 • 2026 • Number 1

Read the Current Issue

Original Research

Innovation in Psychiatric Drug Development: A Quantitative Analysis of FDA-Approved Psychiatric Drugs, 2012–2024

Meta-Analysis

Effectiveness of Peer-Administered Interventions for Perinatal Depression or Anxiety

Original Research

Effect of Adjuvant Metformin on Adherence to and Persistence of Treatment With SGAs in Nondiabetic Patients

Editorial

Thank You to the JCP Community

Editorial

Psychotherapy: Integral to Clinical Psychiatry

Original Research

Trends in Benzodiazepine Prescribing to Adults in the United States

View current Issue

Related Articles

PCC
Article

Psychotropic Medication Monitoring

February 21, 2019

Psychotropic medications provide therapeutic benefits but also carry iatrogenic risks. Medication monitoring helps minimize this risk. This CME journal article offers clinicians a review of guidelines and presents monitoring...
Matthew A. Schreiber, Stephanie C. Armstrong, Jesse D. Markman
PCC
Article

Acute Blood Pressure Changes With Antipsychotic Use

July 19, 2018

Could administration of certain antipsychotic medications be associated with significant acute blood pressure changes? The authors of this study attempted to answer this question by investigating blood pressure changes...
Kristin A. Parks, Clayton G. Parks, Johnathon P. Yost, et al
PCC
Article

Adherence to Follow-Up in First-Episode Psychosis: Ethnicity Factors

June 7, 2018

Do visible minority patients have poorer service engagement and follow-up in mental health care in Canada? The objective of this study was to determine whether visible minority patients with...
Katerina Nikolitch, Andrew Ryder, G. Eric Jarvis

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe
The Journal of Clinical Psychiatry
The Primary Care Companion for CNS Disorders

ELSEWHERE:

  • ABOUT
  • ADVERTISERS
  • MEDIA RELATIONS
  • REPRINTS & PERMISSIONS
  • CONTACT US
  • CUSTOMER SUPPORT

FOLLOW US:

  • X
  • FACEBOOK
  • INSTAGRAM
  • LINKEDIN
  • THREADS
  • BLUESKY
  • SIGN IN

  • JOIN THE EMAIL LIST


SUBSCRIBE NOW
An image of the Psychiatrist.com logo mark
  • Privacy Policy
  • Terms of Use
  • Physicians Postgraduate Press, Inc.
  • JCP ISSN: Online 1555-2101, Print 0160-6689
  • PCC ISSN: Online 2155-7780, Print 2155-7772
  • MedFair.com US Patent No. 684794
  • © Copyright 2026 | Physicians Postgraduate Press, Inc. | LifeLong Learning For Clinicians
  • Sitemap